Investor Overview
Ondine Biomedical Inc. is the global leader in the development of innovative
non-antibiotic therapies for the treatment and prevention of bacterial, fungal and viral infections. Our mission is to create and commercialize leading-edge products that leverage the versatility and efficacy of our platform technology, photodisinfection. Demonstrated efficacy and commercial viability enables Ondine to partner with strategic manufacturing and distribution leaders to achieve maximum worldwide sales coverage.
Ondine’s photodisinfection therapies represent potential non-antibiotic alternatives to a wide range of infections including periodontal disease, ventilator-associated pneumonia and chronic sinusitis. Ondine’s mission is to develop a broad product pipeline of proprietary anti-infective products, leveraging core strengths, product development expertise and strategic relationships.
